Egypt Edition 
MENA+ Edition 
UAE Edition 
Saudi Edition 
AI + Innovation (MENA) 
Infrastructure 
Admaius inks strategic partnership with local pharma player. PLUS: News from Madinet Masr, ACDIMA, Social Housing Fund
Matouk Bassiouny advised Admaius Capital on the transaction and Zilla Capital was the sole financial advisor to Parkville
Arab sovereign funds in talks to acquire 20% of ACDIMA’s pharma ingredients production arm
Ahead of launch, Arab SWFs are vying for a slice in ACDIMA’s pharma ingredients producer: Arab sovereign funds are in…
Acdima to set up USD 165 mn pharma factory
The factory will produce some 28 active substances for the pharma industry\
GSK is staying put — for now
GSK puts Egypt exit on the backburner: GlaxoSmithKline has shelved plans to sell its units in Egypt and Tunisia following…
GSK only has eyes for Hikma
GlaxoSmithKline (GSK) has rejected separate takeover bids from Rameda and Acdima for its Egypt arm, focusing instead on talks with…
A bidding war for GSK’s Egyptian arm?
Acdima may have just touched off a bidding war for GlaxoSmithKline's Egypt business, according to a regulatory filing (pdf) yesterday,…
Acdima signs MoU with SK Plasma to produce plasma-derived products
Acdima Pharma signed an MoU with South Korea’s SK Plasma to produce plasma-derived medicinal products in Egypt, the local press…
ACDIMA Pharma Chairman steps down citing differences with shareholders
MOVES- Chairman Ahmed Hegazy has resigned from his position as chairman of October Pharma, sources close to the company told…